As a practitioner and researcher, I like to share important information on new treatments and clinical trials that may become available to patients and the health care community.A number of research and clinical trials have been completed and undergone in regards to LDN immunotherapies, with phase I and phase II clinical trials successfully run at a number of universities in the United States and Continue Reading about Clinical Trials & Research on Low-Dose Naltrexone (LDN)